Literature DB >> 32572445

Anomalous aortic origin of coronary arteries: an alternative to the unroofing strategy.

Maïra Gaillard1, Margaux Pontailler1, Pichoy Danial1, Anne Moreau de Bellaing1, Régis Gaudin1, Leonora du Puy-Montbrun1, Bari Murtuza1, Ayman Haydar1, Sophie Malekzadeh-Milani2, Damien Bonnet2, Pascal Vouhé1, Olivier Raisky1.   

Abstract

OBJECTIVES: Anomalous aortic origin of a coronary artery (AAOCA) is the second leading cause of sudden death in children and young adults. The most threatening anatomy is an interarterial and an intramural course, both probably involved in ischaemic phenomena and sudden death. The treatment of interarterial AAOCA remains controversial. Most of the published studies describe the results of the unroofing technique. Our study aims to evaluate the results of a different surgical approach.
METHODS: From 2005 to 2019, 61 patients were operated on for an interarterial AAOCA (median age 14.7 years). Forty patients had a right AAOCA, and 21 patients had a left AAOCA including 5 patients with intraseptal course. Seventy percent of patients were symptomatic. Five patients had an aborted sudden cardiac death. Two surgical techniques were used: an 'anatomical' repair for 35 patients (15 left and 22 right AAOCA) or a coronary translocation with creation of a neo-ostia in 19 patients (1 left and 18 right AAOCA). The 5 left AAOCA patients with an intra-septal course required a complete release of the coronary artery from the septum.
RESULTS: There was no early or late postoperative death. Three patients had an acute postoperative ischaemic event. Two patients required immediate angioplasty and stenting: 1 patient (7 years) with a hypoplastic right AAOCA and 1 patient (66 years) for inadequate tailoring after septal release. The third patient required an immediate surgical revision (H-2) for left AAOCA thrombosis at the level of the pericardial patch with full myocardial recovery at discharge. During follow-up, 1 patient with right AAOCA translocation and chronic chest pain required subsequent stenting and finally a coronary artery bypass grafting 2 years after initial surgery. One patient who had an asymptomatic mild right coronary stenosis 1 year after anatomical repair was successfully treated by angioplasty alone. All patients but 1 who underwent coronary translocation are totally asymptomatic. All patients with anatomical repair or septal release are free from ischaemic symptoms.
CONCLUSIONS: Anatomical repair might provide a better protective option for these patients. Unlike unroofing, it treats the entire intramural segment, relocates the ostium at the appropriate sinus level and corrects any acute take-off angle.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Anatomical repair; Anomalous coronary artery; Congenital heart disease; Ostioplasty; Translocation; Unroofing

Mesh:

Year:  2020        PMID: 32572445     DOI: 10.1093/ejcts/ezaa129

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Coronary artery bypass grafting in infants and young children: default or alternative choice?

Authors:  Bahaaldin Alsoufi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

Review 2.  Surgery for Anomalous Aortic Origin of Coronary Arteries: Technical Safeguards and Pitfalls.

Authors:  Massimo A Padalino; Anusha Jegatheeswaran; David Blitzer; Gabriella Ricciardi; Alvise Guariento
Journal:  Front Cardiovasc Med       Date:  2021-05-12

3.  Repair of the left coronary artery originating from right coronary sinus with intramural course.

Authors:  Serdar Başgöze; Ersin Erek
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-01-28       Impact factor: 0.332

Review 4.  Surgical Techniques for the Treatment of Anomalous Origin of Right Coronary Artery From the Left Sinus: A Comparative Review.

Authors:  Lara Gharibeh; Kenza Rahmouni; Seok Joon Hong; Andrew M Crean; Juan B Grau
Journal:  J Am Heart Assoc       Date:  2021-11-02       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.